Cmx001 as Therapy for Severe Adenovirus Infections in Immunocompromised Pediatric Patients: Single Experience in 5 Patients

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ceftazidime as Initial Therapy for Suspected Bacterial Infections in Hospitalized Pediatric Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients With Severe Adenovirus Pneumonia

PLoS ONE
Multidisciplinary
2015English

Bloodstream Infections in Pediatric Hematology/Oncology Patients: Six Years’ Experience of a Single Center in Turkey

Turkish Journal of Medical Sciences
Medicine
2019English

Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children

Pediatrics
Child HealthPediatricsPerinatology
2002English

Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients With Asymptomatic Adenovirus Viremia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Gram Positive Bacterial Infections in Immunocompromised Patients With HIV Infection

BMC Infectious Diseases
Infectious Diseases
2013English

Safety and Efficacy of Liposomal Amphotericin B for the Empirical Therapy of Invasive Fungal Infections in Immunocompromised Patients

Infection and Drug Resistance
Infectious DiseasesPharmacology
2012English

Diagnosis of Pediatric Acute Adenovirus Infections

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2016English

Single Center Experience With Gastrostomy Insertion in Pediatric Patients: A 10-Year Review

Pediatric Gastroenterology, Hepatology and Nutrition
Child HealthHepatologyPediatricsPerinatologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy